2001

Dec 17, 2001
Guidant Announces Strategic Alliance with HeartCenterOnline

Internet Based Channel Provides Comprehensive Information for Heart Patients Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT) today announced a strategic partnership with...

Dec 11, 2001
Guidant Files with FDA for Next-Generation Intravascular Radiotherapy Systemment for High Surgical-Risk Patients

GALILEO III System Designed to Enable Physicians to More Easily and Precisely Treat Longer Heart Blockages Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a...

Dec 7, 2001
Guidant's New Defibrillator Manages Abnormal Heart Rates in Upper and Lower Chambers

European Market Release and U.S First Implant of Dual Chamber Defibrillator with Advanced Atrial Arrhythmia Management Indianapolis, Ind. and St. Paul, MN - Guidant Corporation (NYSE and PCX:...

Nov 27, 2001
Guidant Holds Conference Call to Review MADIT II Study

Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and vascular disease, announced today that it will conduct a...

Nov 26, 2001
Guidant to Participate In Merrill Lynch Medical Technology Fundamentals Conference

Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and vascular disease, announced today that it will...

Nov 20, 2001
Guidant Notified that Landmark Implantable Defibrillator Study Ends Early

MADIT II Study Stopped Due to 30 Percent Mortality Reduction in Heart Attack Survivors with Implantable Defibrillators Indianapolis, IN and St. Paul, MN - The MADIT II investigative team today...

Nov 14, 2001
Guidant Launches Advanced Stent System in Japan

New Technology Offering Provides Significant Benefit to Second Largest Coronary Stent Market in the World Indianapolis, Ind. and Tokyo, Japan. - Guidant Corporation (NYSE and PCX: GDT), a world...

Nov 13, 2001
Guidant Completes Enrollment Of First Drug-Eluting Stent Trial Utilizing Actinomycin-D

Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of coronary artery disease, today announced that it has completed enrollment...

Nov 12, 2001
Results of Guidant's Next Generation Intravascular Radiotherapy System Clinical Trial Revealed

GALILEO INHIBIT Trial Presented Today at American Heart Association Meeting Indianapolis, Ind. and Anaheim, Calif. - The results of Guidant Corporation's (NYSE and PCX: GDT) GALILEO INHIBIT trial...

Nov 12, 2001
Guidant Commends Cook on Promising Results of Latest Paclitaxel-Coated Stent Trial

Indianapolis, Ind. and Anaheim, Calif. - Guidant Corporation (NYSE and PCX: GDT) congratulated Cook Incorporated on the announcement of Cook's highly positive results from its paclitaxel-coated...

Nov 9, 2001
Guidant and Cook Announce FDA Approval To Begin U.S. Clinical Trial With Paclitaxel-Coated Stent

First U.S. Patient Treated in Pivotal Clinical Trial Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT) and Cook Incorporated today announced Investigational Device Exemption (IDE)...

Nov 8, 2001
Guidant to Host Vascular Intervention Investor Briefing at AHA

Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and vascular disease, announced today that it will host an...

Nov 7, 2001
Guidant and Merck KGaA Collaborate on Heart Failure Education

International Symposium Offers Unique Opportunity for Experts in Device Technology and Drug Therapy to Share Knowledge Indianapolis, IN - A major international heart failure symposium co-sponsored...

Nov 6, 2001
Guidant Announces First Human Implant of Newest Active-Fixation Defibrillation Lead

Defibrillation Lead Features Advances in Handling and Visibility for Ease in Positioning Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...

Nov 5, 2001
Guidant's Automated Radiotherapy Treatment for Coronary Artery Disease Receives FDA Approval

GALILEO System Sets New Standards of Precision and Ease of Use Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of coronary...

Oct 18, 2001
Guidant Reports Record Third Quarter Sales of $662 Million

Double Digit Growth from Balanced Geographic Performance; Earnings Per Share Reach $0.40 Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in technology for the treatment...

Oct 15, 2001
Guidant Announces Live Webcast of Annual Analyst Meetin

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and vascular disease, announced today that it will host its annual analyst meeting...

Oct 12, 2001
Guidant Launches Carotid Stent System in Europe

Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and vascular disease, today announced that the company has...

Oct 11, 2001
Guidant Announces Live Webcast of its Third Quarter Earnings Conference Call

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and vascular disease, will conduct a live webcast of its third quarter 2001 earnings...

Oct 10, 2001
Guidant Announces Worldwide Launch of New Product for Treating Peripheral Vascular Disease

Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT) today announced the global launch of its second-generation VIATRAC(tm) 14 PLUS Peripheral Dilatation Catheter...

Oct 9, 2001
Guidant Announces CE Mark Approval and First Implants of Advanced Pacemaker System

New Pacemaker Offers Advanced Therapy, Comprehensive Patient Management and Ease-of-Use Features Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...

Oct 8, 2001
Guidant and Cook Announce Submission of FDA filing to begin U.S. Drug-Coated Stent Trial

Indianapolis, Ind. and Bloomington, Ind. - Guidant Corporation (NYSE and PCX: GDT) and COOK Incorporated today announced that an investigational device exemption (IDE) application has been...

Sep 25, 2001
Guidant Appoints Ralph Hall Deputy General Counsel, Litigation and Compliance

Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT) today announced that Ralph Hall, currently secretary and general counsel, cardiac rhythm management, has been promoted...

Sep 21, 2001
Guidant Strengthens Cardiovascular Product Line by Entering New Segment of Guide Wire Market

Company Launches New Polymer Coated Guide Wire in the U.S. Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT) a world leader in the treatment of coronary artery...

Sep 19, 2001
Guidant Announces Significant Progress in its Multiple Programs for Drug-Coated Stents

Guidant Completes ACTION Clinical Trial Enrollment for FDA Filing; Company Confirms Submission of PMA Amendment for Heart Failure Technology Guidant Completes ACTION Clinical Trial Enrollment for...

Sep 17, 2001
Guidant Announces Market Release of its Most Advanced Pacemaker Systems in Japan

Several New Features Designed to Enhance Patient Management Indianapolis, IN and Tokyo, Japan - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and...

Sep 17, 2001
Guidant Expresses Support for the President and our Leaders

Patients Continue to Receive Medical Device Products on an Expedited Basis Indianapolis, Ind. - Ronald W. Dollens, president and CEO of Guidant Corporation (NYSE and PCX: GDT), expressing support...

Sep 11, 2001
Guidant Cancels Briefing at the Transcatheter Cardiovascular Therapeutics Conference

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT) announced today that it has cancelled its briefing at the Transcatheter Cardiovascular Therapeutics (TCT) conference in Washington,...

Sep 7, 2001
Guidant to Host Briefing at the Transcatheter Cardiovascular Therapeutics Conference

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the medical technology industry, will host a briefing at the Transcatheter Cardiovascular Therapeutics (TCT)...

Aug 23, 2001
Guidant Introduces Next Generation Radiotherapy System Outside of the United States

Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT) announced today that it has received European CE Mark approval of its next generation radiotherapy system. This...

Aug 22, 2001
Nicky Spaulding Promoted to Guidant Management Committee as President, Cardiac Surgery

Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT) announced today that Nicky Spaulding has been promoted to the Guidant Management Committee as president of the...

Aug 20, 2001
Guidant Elaborates on its Distribution Agreement with COOK

Agreement Intended to Accelerate Time to Market and Complements Guidant's Drug-Coated Stent Program. Guidant Announces Live Webcast of its Drug-Coated Stent Briefing Indianapolis, Ind. - Guidant...

Aug 17, 2001
Guidant Receives Approval for Full Market Release of ANCURE System

Less-Invasive Therapy Available to Treat Patients with Abdominal Aortic Aneurysms Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...

Aug 17, 2001
Guidant Appoints Debra F. Minott as Vice President, General Counsel and Secretary

Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT) today announced that Debra F. Minott, currently deputy general counsel and secretary, Guidant, has been promoted to vice president,...

Aug 15, 2001
First Patients Treated with Guidant's Next Generation Coronary Stent

Latest Stent Constructed of New Material Designed to Enhance Performance Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...

Aug 10, 2001
Appellate Court Decision Affirms the Strength of Guidant's Coronary Stent Patents

Indianapolis, Ind. - Guidant Corporation today stated that a recent U.S. Court of Appeals ruling on a coronary stent patent infringement suit affirms the strength of specific Guidant coronary...

Jul 24, 2001
Guidant Announces Worldwide Launch of New Self-Expanding Stent System

New Product Introduction Broadens Guidant's Global Line of Non-Coronary Therapies Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT) today announced the global...

Jul 18, 2001
Guidant Introduces its New Generation of Heart Failure Therapy

European Market Release of CONTAK RENEWAL, First Human Use Worldwide of CONTAK RENEWAL 2 Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT) today announced European market...

Jul 17, 2001
Guidant Reports Second Quarter Sales of $656 Million

Earnings per share reach $0.38. Double-digit sales growth projected for the third and fourth quarters. Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in technology for...

Jul 17, 2001
Physicians Resume Implants with Guidant's ANCURE System

Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, announced today that it has received an...

Jul 13, 2001
Guidant Revises Schedule for Second Quarter Earnings Release and Conference Call

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT) today announced that it has revised the schedule for the company's second quarter earnings press release and conference call from...

Jul 13, 2001
Guidant Corporation Meets With the FDA on CONTAK CD/EASYTRAK System

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT) and the U.S. Food and Drug Administration today met to identify next steps following the recent FDA Circulatory Systems Devices...

Jul 10, 2001
FDA Advisory Committee Elects Not To Recommend Guidant's CONTAK CD for Approval

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), today reported that the Circulatory Systems Device Panel of the U.S. Food and Drug Administration (FDA) elected not to recommend...

Jul 9, 2001
Guidant Receives FDA Approval of First Stent Designed Exclusively for Small Vessels in Patients Presenting with Abrupt and Threatened Abrupt Closure

Stent's Performance in Europe Supports Growth in Guidant's Stent Market Position Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT) today announced that it has...

Jun 19, 2001
Guidant Receives FDA Clearance for New Biliary Stent System

New Product Offering Further Expands Guidant's Stent Product Line Indianapolis, Ind. and Menlo Park, Calif - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...

Jun 5, 2001
Guidant Receives European Approval to Treat Long Coronary Blockages with Radiotherapy

Approval Will Allow Physicians to Treat a Greater Number of Patients Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...

Jun 4, 2001
Guidant Corporation to Donate $1 Million in Medical Technology to the Larry King Cardiac Foundation

Donation to help low-income individuals receive life-saving cardiac therapies LOS ANGELES, CA - During the Larry King Cardiac Foundation fundraiser, "An Evening with Larry King and Friends,"...

May 24, 2001
First Patients Treated With Guidant's Drug-Eluting Stent

Clinical Trial Will Be Basis for CE Mark Approval of MULTI-LINK TETRA-D(tm) Stent Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...

May 23, 2001
Guidant Announces CE Mark Approval and First European Implant of Next-Generation Heart Failure Technology

New Device Includes Diagnostic Capabilities for Better Patient Management Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT) today announced European CE Mark approval of...

May 22, 2001
Guidant Unveils Latest Coronary Stent Technology in Europe

Company Launches MULTI-LINK PENTA Stent Indianapolis, Ind. and Santa Clara, Calif. - Physicians in Europe are getting a glimpse at the latest coronary stent technology, following the European...

May 21, 2001
Guidant Announces Two New Members to its Board of Directors

Former HCFA Administrator and Current Eli Lilly and Company Executive Vice President Added to the Board Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT) announced that Guidant's...

May 21, 2001
Guidant Provides Product Updates at Annual Meeting of Shareholders

Emerging Therapies Position Company for Future Success Indianapolis, Ind. - Ronald W. Dollens, president and CEO of Guidant Corporation (NYSE and PCX: GDT), today provided a positive forecast of...

May 18, 2001
Guidant Announces Live Webcast of its Paris Course Investor Briefing

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular therapy technology, today announced that it will host a live webcast of its briefing at the...

May 18, 2001
Guidant Announces FDA Approval of its Newest Non-Coronary Stent System

Company's Second Non-Coronary Stent System Approved Within the Past Month Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...

May 9, 2001
Guidant Poised for U.S. Launch of Newest Coronary Stent System

Company Receives FDA Approval of MULTI-LINK PENTA Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of coronary artery disease,...

May 8, 2001
Guidant To Participate in Deutsche Banc Alex. Brown's Health Care Conference

>Guidant Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular technology, today announced that it will...

May 4, 2001
Statement from Guidant Corporation Regarding Heart Failure Trial Press Release

Indianapolis, IN and St. Paul, MN - Late this afternoon, various news organizations quoted a U.S. Food and Drug Administration (FDA) spokesperson who commented on Guidant's May 2 release...

May 4, 2001
Guidant Announces First Implant of Ventricular Defibrillator Providing Advanced Atrial Therapies

PRIZM AVT Pulse Generator Receives European CE Mark Approval Indianapolis, IN, and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular technology, today...

May 3, 2001
Guidant Introduces its Most Sophisticated Pacemaker in the U.S.

System Combines Sensor and Diagnostic Capabilities to Enhance Therapy Delivery Indianapolis, IN, and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular...

May 2, 2001
Guidant Completes Heart Failure Trial; Study Designed to Determine Benefits of Combined Cardiac Resynchronization and Defibrillation Therapies

Guidant's System Designed to Treat Heart Failure and Prevent Sudden Cardiac Death. Trial Results Suggest a Slowing of Heart Failure Progression, Improvements in Functional Capacity and Quality of...

Apr 30, 2001
Guidant Announces First Implant of Next Generation Heart Failure Device

Heart Failure Technology Deemed Fileable on an Expedited Basis Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT) today announced the first implant of the CONTAK...

Apr 24, 2001
Guidant Foundation Invests in American Heart Association Heart Failure Initiative

Grant to AHA will Empower Americans with Comprehensive Knowledge About Cardiovascular Disease and Heart Failure Indianapolis, Ind. - The Guidant Foundation today announced that it has presented a...

Apr 23, 2001
Guidant Notifies Physicians of Defibrillators Switching into Built-in Safety Mode

Field Action Results in One-Time Charge to First Quarter Earnings Indianapolis, IN, and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular technology,...

Apr 23, 2001
Guidant Reports All Time Record Sales And Pre-Charge Earnings

Sales Reach $671 million and Generate Adjusted Earnings per share of $0.41 Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in technology for the treatment of cardiac...

Apr 23, 2001
Guidant Announces Stock Repurchase Program

Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the medical technology industry, today announced that it intends to repurchase up to $200 million of its common shares...

Apr 19, 2001
Study Shows Value of Implantable Defibrillation Therapy vs. Drugs

Guidant to Apply for New Indication Based on Study Results Indianapolis, IN, and St. Paul, MN - Results of the first clinical study to demonstrate that implantable cardioverter defibrillators...

Apr 18, 2001
Guidant Announces Live Webcast of its First Quarter Earnings Conference Call

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the medical technology industry, will conduct a live webcast of its first quarter 2001 earnings conference call on...

Apr 18, 2001
Guidant Announces European Approval and FDA Filing of MULTI-LINK PIXEL Coronary Stent System

New System Allows Physicians to Treat Wider Range of Coronary Blockages Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...

Apr 10, 2001
Guidant Pre-Announces All-Time Record Quarterly Sales and Earnings

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the medical technology industry, today announced revenue of $671 million and adjusted earnings of $126.9 million for...

Apr 5, 2001
Guidant Supports Fellows Course to Educate Future Interventional Cardiologists

International Symposium Covers Latest Techniques and Technologies for Treating Coronary and Peripheral Vascular Disease Indianapolis, Ind. and Santa Clara, Calif. - In an effort to equip the next...

Mar 27, 2001
Guidant Announces Nomination of Former HCFA Administrator to Its Board of Directors

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the medical technology industry, today announced that its Board of Directors has nominated Nancy-Ann DeParle to...

Mar 26, 2001
Guidant's Intravascular Radiotherapy System Enjoys Continued Success in Europe

Company Satisfies European Post-Marketing Requirements for its GALILEO System Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment...

Mar 20, 2001
Clinical Study Demonstrates Decreased Risk of Neurological Complications for Patients Undergoing Beating Heart Surgery

Indianapolis, Ind. and Cupertino, Calif. - Data from a recent clinical study1 show that among patients experiencing neurological complications after coronary artery bypass surgery, those who...

Mar 16, 2001
Guidant Attains U.S. Coronary Angioplasty Market Leadership, Reinforcing its Position as the Global Leader in Interventional Cardiology

Company Announces Worldwide Approval of POWERSAIL and HIGHSAIL Coronary Dilatation Catheters Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT) a world leader in...

Mar 16, 2001
Guidant Voluntarily Halts Production and Sales of Endovascular Graft

Patients With Implanted Devices Not Affected by this Action Indianapolis, IN and Menlo Park, CA - Guidant Corporation (NYSE and PCX: GDT) today announced it has voluntarily halted production and...

Mar 15, 2001
Guidant to Host General Briefing at the American College of Cardiology Meeting

All Are Invited to Access the Guidant Briefing By Live Webcast Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the medical technology industry, will host a general...

Feb 28, 2001
Guidant Announces FDA Filing for Heart Failure Treatment

Company First to File for Approval of Cardiac Resynchronization Therapy Defibrillator for Heart Failure Patients Indianapolis, IN, and St. Paul, MN - Guidant Corporation (NYSE and PCX:GDT), a...

Feb 21, 2001
Guidant Expands its Product Offerings for the Treatment of Coronary Artery Disease

Company Receives CE Mark Approval on Latest Coronary Stent System and Filed for U.S. Approval Earlier This Year Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX:...

Feb 16, 2001
Guidant Launches New Coronary Stent System in Japan

Company Also Increases Direct Sales Organization to Support New Product Introductions Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...

Feb 6, 2001
Guidant's Drug Eluting Stent System Shown to Reduce Restenosis in Pre-Clinical Models

Human Evaluation Expected to Begin in the Second Quarter of This Year Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...

Feb 5, 2001
Guidant to Participate in Merrill Lynch Global Healthcare Conference

Investors Are Invited to Access the Guidant Presentation by Live Webcast INDIANAPOLIS, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in medical technology, today announced that it...

Jan 30, 2001
Guidant Reports Fourth Quarter Sales Increase of 13 Percent to $649 Million; Record Fourth Quarter Earnings, as Adjusted, of $0.41 per Share

Full Year Net Income Grew 20 Percent, as Adjusted Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in medical technology, today reported fourth quarter sales were $648.8...

Jan 29, 2001
Guidant Introduces New Beating Heart Coronary Artery Bypass Platform

Indianapolis, Ind. and Cupertino, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular disease, announced today the introduction of a new product...

Jan 29, 2001
Guidant Announces Live Webcast of its Fourth Quarter and Year-End 2000 Earnings Conference Call

INDIANAPOLIS, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the medical technology industry, will conduct a live webcast of its fourth quarter and year-end 2000 earnings...

Jan 29, 2001
Guidant to Focus Heart Failure Efforts on Cardiac Resynchronization Therapy

Opts not to Acquire Impulse Dynamics Technology; Will Recognize Charge in Fourth Quarter of 2000 Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a world leader in...

Jan 29, 2001
Guidant Organizes to Enhance Focus on New Therapies

Company Forms Endovascular Solutions and Guidant Cardiac Surgery Groups Indianapolis, Ind. and Santa Clara and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...

Jan 29, 2001
Guidant Announces Comprehensive Web Site With Patient- and Physician-Friendly Focus

New Site Responds to Consumer Interest in Healthcare Information Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in medical technology, announced today its new...

Jan 26, 2001
Guidant to Host Investor Briefing at American College of Cardiology Meeting

Jan 26, 2001
New Study Shows Guidant's Heart Failure Technology Delivers a Marked Improvement for a Solid Majority of Patients

Company's CONTAK Registry Reflects Experience of 1,000 European Heart Failure Patients Indianapolis, IN, and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a global leader in heart...

Jan 4, 2001
Guidant Pre-Announces Fourth Quarter Revenues and Impact on Earnings Per Share

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the medical technology industry, announced fourth quarter revenues of approximately $649 million, reflecting sales...

Jul 19, 2001
First Patients in Japan Treated with Guidant's Carotid Stent

Clinical Study to Evaluate Novel Stroke Prevention Alternative for Japanese Patients Indianapolis, Ind. and Tokyo, Japan - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment...

Apr 19, 2001
Guidant Expands Company's Non-Coronary Stent Offering

Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and vascular disease, announced today it has received...

Show per page

Top